A cell-based vaccine designed to promote immune responses against survivin, a protein that helps tumor cells survive and expand, was…
Articles by Lindsey Shapiro, PhD
The U.S. Food and Drug Administration (FDA) has granted conditional approval to Pfizer‘s elranatamab — an antibody therapy to…
A European Medicines Agency committee has recommended that one antibody-based cancer therapy from Janssen Pharmaceuticals be approved for the…
The International Myeloma Foundation (IMF) will host its second in-person Patient and Family Seminar of the year on…
Janssen is asking the U.S. Food and Drug Administration (FDA) to expand approval its cell therapy Carvykti (ciltacabtagene…
ISB 1442, Ichnos Sciences’Â investigational bi-specific antibody-based treatment, has earned orphan drug designation from the U.S. Food and Drug Administration…
Multiple myeloma patients in the U.S. will now have access to Rapid Novor‘s noninvasive and highly sensitive blood…
The U.S. Food and Drug Administration (FDA) has granted fast track and regenerative medicine advanced therapy designations to CT103A, IASO…
Extremes in body mass index (BMI) — a ratio of weight to height that’s used to estimate a person’s healthy…
In people with newly diagnosed multiple myeloma following a stem cell transplant, a triple-combination maintenance therapy — of…